Remove Economics Remove Mergers Remove Pharmaceutical
article thumbnail

Learning Old Lessons From Recent Life Sciences Earnout Disputes: Above All Else, Words Matter

Cooley M&A

Alexion Pharmaceuticals (Del. In its opinion, the court held that J&J breached its obligations in the merger agreement and the implied covenant of good faith and fair dealing regarding the iPlatform regulatory milestones, but not certain other regulatory milestones or net sales milestones. In both Fortis v.

article thumbnail

Managing Product Shortages through Strategic M&A: Building a Resilient Supply Chain

Sun Acquisitions

These shortages can result from various factors, including natural disasters, geopolitical tensions, economic instability, and unexpected surges in demand. To mitigate these risks and build more resilient supply chains, companies are increasingly turning to strategic mergers and acquisitions (M&A).

M&A 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Shareholders vs. Stakeholders - Understanding Corporate Responsibilities

Peak Frameworks

Proponents argue that by fulfilling this responsibility, firms indirectly benefit society by driving economic growth and innovation. Stakeholder Interests: It's vital when advising companies on public relations during significant corporate moves or when assessing the socio-economic implications of major mergers on local communities.

article thumbnail

The Education Technology (EdTech) Industry: Overview of Mergers, Acquisitions and Venture Capital Trends & Investments

InvestmentBank.com

The benefits of VR are not limited to language immersion, architecture, interior design, space expedition, biology, chemistry or pharmaceutical practices. They also have developed Daydream Labs where employees can be trained visually and interactively, resulting in a faster learning process [9].

article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40
article thumbnail

Rationalize for Success: The Strategic Role of Rationalization in M&A

Devensoft

Mergers and acquisitions (M&A) constitute intricate and frequently risky transactions with significant implications for stakeholders. Due Diligence Guide for Today’s M&A Navigate M&A due diligence in a turbulent economic landscape with confidence.

M&A 52
article thumbnail

MAEjor Ruling: Delaware Court of Chancery Finds Target Suffers Material Adverse Effect and Acquirer Could Back Out of Transaction

Cooley M&A

M&A practitioners have long advised boards of directors that the Delaware courts have never found that the events or circumstances in a particular transaction met the contractual standard of having a material adverse effect (or MAE) as defined in a merger or acquisition agreement. The Merger Agreement. Fresenius Kabi AG , C.A.